United Kingdom

People: Cytokinetics Inc (CYTK.OQ)

CYTK.OQ on NASDAQ Stock Exchange Global Select Market

19 Aug 2019
Change (% chg)

$0.73 (+5.51%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Jaw, Ching 

Mr. Ching Jaw serves as Chief Financial Officer, Senior Vice President of the company. He served as Chief Financial Officer of North America Pharmaceuticals at Sanofi, a multinational pharmaceutical company, from 2015 to 2017 and as the Chair of the North America Regional Finance Council. From 2012 to 2015, Mr. Jaw was Chief Financial Officer for Ventana Medical Systems, a member of the Roche Group. With Genentech since 2001, and then Roche, following their acquisition of Genentech, Mr. Jaw has held a wide variety of finance positions over the years, including two years as Chief Financial Officer of Roche in Taiwan and as Head of R&D Finance. A former Army Platoon Commander and Liaison Officer in the Taiwanese Army, Mr. Jaw holds a Bachelor of Science degree in Naval Architecture from National Taiwan University, a Master of Science in Aerospace Engineering from the University of Michigan, and an M.B.A. in Finance and General Management from the University of Chicago Graduate School of Business.

Basic Compensation

Total Annual Compensation, USD 337,884
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 762,005
Fiscal Year Total, USD 1,099,890

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leonard Patrick Gage


Robert Blum


Ching Jaw


Fady Malik


David Cragg


Robert Wong

As Of  31 Dec 2017